5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR

No abstract is available for this paper.

• Publication year

  2003

• Venue

  HYPERTENSION

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000090095.87899.36PMID 12939232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels

  2003cited by this paper
• The Nitric Oxide- and Prostaglandin-Independent Component of the Renal Vasodilator Effect of Thimerosal Is Mediated by Epoxyeicosatrienoic Acids

  2003cited by this paper
• Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension

  2002cited by this paper
• Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.

  2002cited by this paper
• Epoxyeicosatrienoic Acid–Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR

  2001cited by this paper
• Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid

  2001cited by this paper
• CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR.

  2001cited by this paper
• 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure

  2001cited by this paper
• Is EDHF an epoxyeicosatrienoic acid?

  2000cited by this paper
• Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

  2000cited by this paper
• Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.

  2000cited by this paper
• Angiotensin II releases 20-HETE from rat renal microvessels.

  2000cited by this paper
• Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness

  1999cited by this paper
• Cytochrome P450 2C is an EDHF synthase in coronary arteries

  1999cited by this paper
• Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.

  1998cited by this paper
• NO-independent vasodilation to acetylcholine in the rat isolated kidney utilizes a charybdotoxin-sensitive, intermediate-conductance Ca(++)-activated K+ channel.

  1998cited by this paper
• NO-Independent Vasodilation to Acetylcholine in the Rat Isolated Kidney Utilizes a Charybdotoxin-Sensitive , Intermediate-Conductance Ca 11-Activated K 1 Channel 1

  1998cited by this paper
• Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR.

  1998cited by this paper
• Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors.

  1998cited by this paper
• A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol.

  1998cited by this paper
• Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.

  1998cited by this paper
• Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II.

  1997cited by this paper
• Hyperpolarizing factors.

  1997cited by this paper
• Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators.

  1997cited by this paper
• The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review.

  1997cited by this paper
• Increased expression of Ca2+-sensitive K+ channels in aorta of hypertensive rats.

  1997cited by this paper
• Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.

  1997cited by this paper
• Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

  1997cited by this paper
• Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity.

  1996cited by this paper
• Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system

  1996cited by this paper
• Actions of epoxygenase metabolites on the preglomerular vasculature.

  1996cited by this paper
• Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

  1996cited by this paper
• Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone.

  1995cited by this paper
• Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure.

  1994cited by this paper
• Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle

  1994cited by this paper
• Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet.

  1994cited by this paper
• Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid.

  1993cited by this paper
• 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries.

  1993cited by this paper
• Cytochrome P-450-dependent vasodilation of rat kidney by arachidonic acid.

  1991cited by this paper
• Cytochrome P-450 metabolism of arachidonic acid.

  1991cited by this paper
• Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat.

  1991cited by this paper
• Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries.

  1991cited by this paper
• Increased Vascular Responsiveness to Bradykinin in Kidneys of Spontaneously Hypertensive Rats Effect of Nω‐Nitro‐L‐Arginine

  1991cited by this paper
• Role of endoperoxides in arachidonic acid‐induced vasoconstriction in the isolated perfused kidney of the rat

  1989cited by this paper

• Homocysteine Attack on Vascular Endothelium—Old and New Features

  2025cites this paper
• Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats

  2021cites this paper
• Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation

  2021cites this paper
• Effects of epoxygenases on the nonadrenergic noncholinergic relaxant responses induced by electrical field stimulation in rabbit corpus cavernosum

  2019cites this paper
• Arachidonic Acid Metabolism and Kidney Inflammation

  2019cites this paper
• EET Intervention on HO-1 Prevent Obesity Derived Cardiovascular Diseases

  2018cites this paper
• 5,6‐&dgr;‐DHTL, a stable metabolite of arachidonic acid, is a potential EDHF that mediates microvascular dilation

  2017cites this paper
• Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.

  2017cites this paper
• 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1.

  2015cites this paper
• Modulation of Arachidonic Acid Metabolism in the Rat Kidney by Resveratrol: Implications for Regulation of Blood Pressure

  2015cites this paper
• Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids

  2014cites this paper
• Modulation of Arachidonic Acid Metabolism in the Rat Kidney by Sulforaphane: Implications for Regulation of Blood Pressure

  2014cites this paper
• Vasodilatory effect of 14,15-epoxyeicosatrienoic acid on mesenteric arteries in hypertensive and aged rats.

  2014cites this paper
• Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

  2012cites this paper
• Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid.

  2012cites this paper
• Sex hormones, metabolic syndrome and kidney.

  2011cites this paper
• Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo

  2011cites this paper
• Endothelium-Derived Hyperpolarizing Factor and Vascular Function

  2011cites this paper
• Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.

  2011cites this paper
• Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome.

  2010cites this paper
• Vascular pharmacology of epoxyeicosatrienoic acids.

  2010cites this paper
• Mammalian epoxide hydrolases in xenobiotic metabolism and signalling

  2009cites this paper
• Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo

  2009cites this paper
• Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation

  2009cites this paper
• Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney.

  2008cites this paper
• 15-Lipoxygenase metabolites contribute to age-related reduction in acetylcholine-induced hypotension in rabbits.

  2008cites this paper
• Role of TRPV1 channels in renal haemodynamics and function in Dahl salt‐sensitive hypertensive rats

  2008influential citation
• CHAPTER 23 – Renal Cortical and Medullary Microcirculations: STRUCTURE AND FUNCTION

  2008cites this paper
• Renal Cortical and Medullary Microcirculations

  2008cites this paper
• Chapter 33 – Multiple Roles of Eicosanoids in Blood Pressure Regulation

  2007cites this paper
• Oxidative modulation of transient potassium current by arachidonic acid in brain central neurons

  2007cites this paper
• Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity.

  2007cites this paper
• Endothelium-derived epoxyeicosatrienoic acids and vascular function.

  2006cites this paper
• Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.

  2006cites this paper
• Systemic blood pressure response to the inhibition of two hyperpolarizing pathways: a comparison to NO-synthase inhibition.

  2006cites this paper
• Evaluation of herbs as potential alternatives for bear bile and rhino horn used in traditional Chinese medicines: chemical and biological analysis.

  2006cites this paper
• Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids

  2006cites this paper
• Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.

  2005cites this paper
• Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids.

  2004cites this paper
• Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid‐dependent epoxygenases ‡

  2004cites this paper
• Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure.

  2004cites this paper
• Aged Spontaneously Hypertensive Rats Exhibit a Selective Loss of EDHF-Mediated Relaxation in the Renal Artery

  2003cites this paper